Literature DB >> 22765769

Crotalidae polyvalent immune Fab: a guide to its use in North American crotaline envenomation.

Gillian M Keating1, Katherine A Lyseng-Williamson.   

Abstract

Intravenous crotalidae polyvalent immune Fab (CroFab(®)) is effective in patients with minimal, moderate or severe crotaline envenomation, halting the progression of local venom effects and ameliorating haematological and other systemic abnormalities of envenomation. Despite treatment, patients may experience delayed-onset or recurrent venom effects (e.g. coagulopathy). Intravenous crotalidae polyvalent immune Fab is generally well tolerated, with acute hypersensitivity reactions being the most commonly occurring adverse event.

Entities:  

Mesh：

Substances：

Year:  2012        PMID： 22765769     DOI： 10.1007/bf03261909

Source DB:  PubMed          Journal:  Clin Drug Investig        ISSN： 1173-2563            Impact factor:   2.859


  20 in total

Review 1.  North American snake envenomation: diagnosis, treatment, and management.

Authors:  Barry S Gold; Robert A Barish; Richard C Dart
Journal:  Emerg Med Clin North Am       Date:  2004-05       Impact factor: 2.264

2.  Successful treatment of crotalid-induced neurotoxicity with a new polyspecific crotalid Fab antivenom.

Authors:  R F Clark; S R Williams; S P Nordt; L V Boyer-Hassen
Journal:  Ann Emerg Med       Date:  1997-07       Impact factor: 5.721

Review 3.  Venoms, antivenoms and immunotherapy.

Authors:  J P Chippaux; M Goyffon
Journal:  Toxicon       Date:  1998-06       Impact factor: 3.033

4.  Biphasic rattlesnake venom-induced thrombocytopenia.

Authors:  Steven R Offerman; J David Barry; Aaron Schneir; Richard F Clark
Journal:  J Emerg Med       Date:  2003-04       Impact factor: 1.484

Review 5.  Crotalidae polyvalent immune Fab: in patients with North American crotaline envenomation.

Authors:  Gillian M Keating
Journal:  BioDrugs       Date:  2011-04-01       Impact factor: 5.807

6.  Short-term outcomes after Fab antivenom therapy for severe crotaline snakebite.

Authors:  Eric J Lavonas; Jamie Kokko; Tammi H Schaeffer; Sara L Mlynarchek; Gregory M Bogdan; Richard C Dart
Journal:  Ann Emerg Med       Date:  2010-10-16       Impact factor: 5.721

7.  Incidence of immediate hypersensitivity reaction and serum sickness following administration of Crotalidae polyvalent immune Fab antivenom: a meta-analysis.

Authors:  Tammi H Schaeffer; Vaishali Khatri; Liza M Reifler; Eric J Lavonas
Journal:  Acad Emerg Med       Date:  2012-02       Impact factor: 3.451

8.  Crotalidae polyvalent immune Fab (ovine) antivenom is efficacious for envenomations by Southern Pacific rattlesnakes (Crotalus helleri).

Authors:  Sean P Bush; Steven M Green; James A Moynihan; William K Hayes; Michael D Cardwell
Journal:  Ann Emerg Med       Date:  2002-12       Impact factor: 5.721

9.  Comparison of a new ovine antigen binding fragment (Fab) antivenin for United States Crotalidae with the commercial antivenin for protection against venom-induced lethality in mice.

Authors:  P Consroe; N B Egen; F E Russell; K Gerrish; D C Smith; A Sidki; J T Landon
Journal:  Am J Trop Med Hyg       Date:  1995-11       Impact factor: 2.345

10.  Unified treatment algorithm for the management of crotaline snakebite in the United States: results of an evidence-informed consensus workshop.

Authors:  Eric J Lavonas; Anne-Michelle Ruha; William Banner; Vikhyat Bebarta; Jeffrey N Bernstein; Sean P Bush; William P Kerns; William H Richardson; Steven A Seifert; David A Tanen; Steve C Curry; Richard C Dart
Journal:  BMC Emerg Med       Date:  2011-02-03
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.